-- 
Gap, Newmont, Salesforce.com, Xenoport: U.S. Equity Preview

-- B y   I n y o u n g   H w a n g
-- 
2011-04-07T12:51:11Z

-- http://www.bloomberg.com/news/2011-04-06/bed-bath-beyond-immucor-pep-boys-ruby-tuesday-u-s-equity-preview.html
Shares of the following companies
may have unusual moves in U.S. trading. Stock symbols are in
parentheses and prices are as of 8:40 a.m. in New York.  Bed Bath & Beyond Inc. (BBBY)   gained 11 percent to
$54.68. The home furnishings retailer forecast annual earnings
of $3.38 to $3.53 a share. That compares with the average
analyst projection of $3.33, Bloomberg data show.        Costco Wholesale Corp. (COST)   rose 1.9 percent to
$76.40. The largest U.S. warehouse-club chain reported total
comparable sales rose 13 percent in March, beating the 7.4
percent estimate.        Gap Inc. (GPS)   slipped 3.3 percent to $22.30. The
largest U.S. apparel chain reported same-store sales in March
were down 10 percent. The San Francisco-based company forecast
first-quarter earnings will be less than the average analyst
estimate of 44 cents a share.  Immucor Inc. (BLUD)   climbed 7.3 percent to $21.43. The
maker of products used to screen donated blood reported third-
quarter earnings of 32 cents a share, beating the average
analyst projection of 26 cents a share, according to data
compiled by Bloomberg.  Immunogen Inc. (IMGN)   advanced 7.2 percent to $9.97. The
Waltham, Massachusetts-based drugmaker said that patients
treated with T-DM1, which consists of the company’s DM1 cancer
cell-killing agent, had a significant improvement in
“progression-free survival.”  Limited Brands Inc. (LTD US) increased 2.9 percent to
$36.25. The clothing retailer that owns Victoria’s Secret and
Bath & Body Works reported same-store sales in March rose 14
percent, beating the 1.1 percent estimate by Retail Metrics Inc.  Merck & Co. (MRK US): The second-biggest U.S. drug company
said it failed to win U.S. approval to expand use of the
cervical-cancer vaccine Gardasil to older women.  Newmont Mining Corp. (NEM)   rose 1 percent to $57. The
largest U.S. gold producer plans to raise annual production of
the metal to 7 million ounces by 2017 and link its dividend
payment to the average sales price for the metal. The 2017
output target represents an increase of about 35 percent over
the company’s 2011 forecast of 5.1 million to 5.3 million
ounces.  Pep Boys - Manny, Moe & Jack (PBY US) rose 3 percent to
$14.02. The Philadelphia-based auto-parts retailer reported
fourth-quarter earnings excluding some items that exceeded
analyst estimates and said sales increased 5.4 percent to $477.4
million.  Pier 1 Imports Inc. (PIR)   rose 7.7 percent to $11.35.
The home-furnishings retailer reported fourth-quarter earnings
of 48 cents a share, beating the average analyst estimate by 1
cent.  Power-One Inc. (PWER)   declined 1.8 percent to $8.14. The
maker of electrical inverters said first-quarter sales were $245
million at most, trailing its previous forecast of at least $260
million.  Ruby Tuesday Inc. (RT)   slumped 10 percent to $12. The
casual-dining chain cut its 2011 earnings forecast to a range of
74 cents to 82 cents a share, from 76 cents to 87 cents a share.
That’s below the average analyst projection of 91 cents a share.        Salesforce.com Inc. (CRM)   climbed 1.9 percent to
$133.91. The largest supplier of customer-management software
was raised to “outperform” from “market perform” at FBR
Capital Markets Corp.  Travelzoo Inc. (TZOO)   dropped 2.7 percent to $75.80. The
Internet travel marketer was cut to “hold” from “buy” at
Benchmark Co.  WD-40 Co. (WDFC)  : The San Diego-based maker of
lubricants and hand soap cut its 2011 earnings forecast to a
range from $2.23 to $2.35 a share, from $2.25 to $2.40 share.
The average analyst forecast was $2.31 a share, Bloomberg data
show.  XenoPort Inc. (XNPT)   rallied 65 percent to $10.54. The
drugmaker and GlaxoSmithKline Plc (GSK LN) won U.S. approval for
a new treatment for restless legs syndrome after more than a
year of delays.  Zumiez Inc. (ZUMZ)   increased 1 percent to $27.77. The
retailer based in Everett,  Washington , said March comparable
store sales increased 8.9 percent, beating the 3.2 percent
estimate from Retail Metrics.  To contact the reporter on this story:
Inyoung Hwang in  New York  at 
 ihwang7@bloomberg.net .  To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 